Michael E. Weinblatt, MD, co-director of clinical rheumatology at Brigham and Women’s Hospital in Boston, wrapped up the session with high praise for the task force’s work. He noted that the criteria will set the stage for earlier identification and treatment of disease. “For the first time, [the classification criteria] now appreciate the diversity of a heterogeneous disease and will improve patient care,” he said.
Gretchen Henkel is a freelance journalist based in California.
